Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
In an interview at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, Dr Ghobrial explains how
“This is very important, we screen for other cancers; mammography for breast cancer, colonoscopy for colon cancer. Yet we don’t do just one blood test to see if patients have a blood cancer or not, and this will change with the PROMISE study.”
The PROMISE Study has the following eligibility requirements:
✔ Participants must be between the ages of 40 and 75,
✔ Have a first degree relative with MM or a precursor condition to MM
OR
✔ Self-identify as being of African descent, and not currently under treatment for MM or a precursor condition.
An individual who qualifies for the PROMISE study enrolls, consents, and completes all steps of the study online at:
Following online registration, the participant receives a blood draw kit in the mail which can be brought to a Quest Diagnostics clinic in their area.
Clinical process
✉ Mailing of blood drawing kit
💉 Drawing of blood in the clinic
🔬 One tube sent to Mayo Clinic for medical testing, two sent to Harvard for continued research
🏥 Clinical consultation and advice
How can you help this important project?
① Ask the PROMISE study to send brochures to your clinic by contacting the team at promisestudy@partners.org or 617-582-8544
② Recommend that patient family members visit the PROMISE study website at www.enroll.promisestudy.org